Page last updated: 2024-11-12

luteolin-7-o-glucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

luteolin-7-O-glucuronide: from the leaves and flowers of the cannabinoid-free cannabis (Cannabis sativa subsp. sativa L., Cannabaceae); structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
CannabisgenusThe plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber.[MeSH]CannabaceaeA plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. It is most notable for the members, Cannabis and Hops.[MeSH]

Cross-References

ID SourceID
PubMed CID13607752
SCHEMBL ID24449203
MeSH IDM0426452

Synonyms (8)

Synonym
luteolin-7-beta-d-glucuronide
2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4h-1-benzopyran-7-yl-|a-d-glucopyranosiduronic acid
3 inverted exclamation marka,4 inverted exclamation marka,5,7-tetrahydroxy-7-|a-d-glucopyranuronoside flavone
luteolin-7-o-glucuronide
6-[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
luteolin-7-glucuronide;luteolin 7-o-beta-d-glucuronopyranoside; luteolin 7-o-beta-glucuronide;luteolin 7-o-beta-glucuronopyranoside
BCP29714
SCHEMBL24449203

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The validated method was successfully applied to a pharmacokinetic study of the three flavonoid glycosides in beagle dog plasma after intravenous administration of the traditional Chinese medicinal preparation: Kudiezi injection."( UFLC-MS/MS method for simultaneous determination of luteolin-7-O-gentiobioside, luteolin-7-O-β-D-glucoside and luteolin-7-O-β-D-glucuronide in beagle dog plasma and its application to a pharmacokinetic study after administration of traditional Chinese med
Bi, K; Chen, X; Han, F; Liu, R; Tang, Z; Yin, R; Zhao, X, 2013
)
0.39

Bioavailability

ExcerptReferenceRelevance
" Oral bioavailability of luteolin is low owing to extensive metabolism."( Importance of OATP1B1 and 1B3 in the Liver Uptake of Luteolin and Its Consequent Glucuronidation Metabolites.
Jiang, Y; Ruan, J; Wang, C; Yuan, Y; Zhang, C; Zhang, H; Zhi, H, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (16.67)29.6817
2010's12 (66.67)24.3611
2020's3 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.74 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index40.36 (26.88)
Search Engine Supply Index2.92 (0.95)

This Compound (27.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]